Scientists may have discovered a powerful new link between the gut microbiome, aging, and liver cancer. New research presented at Digestive Disease Week® (DDW) 2026 suggests that restoring your gut bacteria to a more youthful state may protect your liver, reduce age-related damage, and lower your risk of cancer.
The findings come from studies in mice that focused on the microbiome, the vast community of bacteria and other microorganisms that live in the digestive system. Researchers found that when they reintroduced older mice with their own young gut bacteria, it had significant effects throughout the body, especially in the liver.
Aging mice with preserved young gut microbiota
To test this idea, the scientists collected fecal samples from eight young mice and stored them for later use. As the mice aged, the researchers transplanted the stored samples into the same animals through a process known as fecal microbiota transplantation (FMT).
Another group of eight aged mice served as controls and were given sterile fecal material instead. The researchers also included a small group of young mice to provide a baseline comparison.
By the end of the study, the mice that had restored their youthful microbiomes did not develop liver cancer. In contrast, two out of eight untreated aged mice developed liver cancer. Treated mice also showed lower levels of inflammation and less liver damage.
“We learned from this study that microbiome aging does not simply reflect the aging process, but actively contributes to liver dysfunction and cancer risk,” said Qingjie Li, Ph.D., associate professor in the Department of Gastroenterology and Hepatology at the University of Texas Medical Branch and principal investigator of the study. “The microbiome has a broader impact on the body’s cancer defenses than previously understood.”
Researchers discover changes in cancer-related genes
After completing the in vivo study, the research team took a closer look at the mice’s liver tissue. They found important differences related to MDM2, a gene already associated with the development of liver cancer.
Young mice had lower levels of MDM2 protein, while untreated older mice had much higher levels of MDM2 protein. Older mice given a restored microbiome had suppressed MDM2 levels more similar to those seen in younger animals.
“By restoring a more youthful microbiome, we can reverse several core hallmarks of aging, including inflammation, fibrosis, mitochondrial loss, telomere loss, and DNA damage, at both the molecular and functional levels,” said Dr. Lee.
Early heart research led to discovery
The liver findings were an unexpected revelation from previous research examining the influence of the microbiome on heart health. In previous heart studies, scientists observed that altering gut bacteria appeared to improve heart function.
However, when researchers later analyzed tissue samples, they noticed an even stronger effect in the liver. This observation led the team to investigate the relationship more deeply.
To reduce the chance of immune complications or infections, the researchers used each mouse’s preserved microbiome rather than relying on donor samples. They said this approach also produces a clearer proof of concept for potential future human studies.
Dr. Lee emphasized that this finding is limited to animal studies and cannot yet be applied to humans. Still, he said the team hopes to begin human clinical trials first in the near future.
